Tianjin Medical University: #349 in the world for Pharmacology, Toxicology & Pharmaceutics collaboration
Tianjin Medical University stands at #349 of 844 universities worldwide on the Pharmacology, Toxicology & Pharmaceutics collaboration index, the strongest of its 20 subject standings in the 2026 Research Collaboration Index, published today.
The standing rests on the open scholarly record: 89 co-authored works in the field over 2021 to 2025, built with 51 collaborating institutions across 9 countries, with a field-weighted citation impact of 1.58.
Tianjin Medical University is ranked #753 in the world.
The full index, all 26 subject rankings and complete methodology are now public.
Every figure derives from the open global research record and is checkable at source.
For universities
The GRP Partnership Intelligence Platform
Your university beside the peers you choose, across both GRP indices: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. A partner service now onboarding founding partner universities: enquire, and the GRP team will confirm availability and pricing for your university.